BOLT: Bolt Biotherapeutics, Inc. Stock

by  •  • Comments Off on BOLT: Bolt Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 28.06
Enterprise Value ($M) 23.80
Book Value ($M) 104.16
Book Value / Share 2.73
Price / Book 0.27
NCAV ($M) 56.32
NCAV / Share 1.48
Price / NCAV 0.50

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.33
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 5.68
Current Ratio 5.68

Balance Sheet (mrq) ($M)
Current Assets 95.06
Assets 142.89
Liabilities 38.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.88
Operating Income -76.20
Net Income -69.20

Cash Flow Statement (mra) ($M)
Cash From Operations -69.53
Cash from Investing 71.04
Cash from Financing 0.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Citadel Advisors Llc 6.50
02-14 13G/A Tang Capital Partners Lp 9.60 33.67
02-13 13G/A Vivo Capital VIII, LLC 5.50
02-12 13D/A Pivotal bioVenture Partners Fund I, L.P. 8.10 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 40,434 137,653 29.37
2024-07-25 26,262 138,720 18.93
2024-07-24 11,351 63,681 17.82
2024-07-23 12,516 127,432 9.82
2024-07-22 28,949 81,789 35.39

(click for more detail)

Similar Companies
BLUE – bluebird bio, Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc. BPMC – Blueprint Medicines Corporation
CABA – Cabaletta Bio, Inc.


Financial data and stock pages provided by
Fintel.io